000 01194 a2200325 4500
005 20250513093256.0
264 0 _c19960911
008 199609s 0 0 eng d
022 _a0271-0749
024 7 _a10.1097/00004714-199604001-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKeck, P E
245 0 0 _aOutcome in the pharmacologic treatment of bipolar disorder.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_cApr 1996
300 _a15S-23S p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntimanic Agents
_xadverse effects
650 0 4 _aBipolar Disorder
_xdiagnosis
650 0 4 _aCarbamazepine
_xadverse effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLithium
_xadverse effects
650 0 4 _aPsychotropic Drugs
_xadverse effects
650 0 4 _aTreatment Outcome
650 0 4 _aValproic Acid
_xadverse effects
700 1 _aMcElroy, S L
773 0 _tJournal of clinical psychopharmacology
_gvol. 16
_gno. 2 Suppl 1
_gp. 15S-23S
856 4 0 _uhttps://doi.org/10.1097/00004714-199604001-00003
_zAvailable from publisher's website
999 _c8705238
_d8705238